Mark J. Alexander
Acceleron Pharma (United States)(US)
Publications by Year
Research Areas
Neuropeptides and Animal Physiology, Hypothalamic control of reproductive hormones, Receptor Mechanisms and Signaling, Pulmonary Hypertension Research and Treatments, Neuroendocrine regulation and behavior
Most-Cited Works
- → Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis(2014)425 cited
- → Neurotensin and Neuroendocrine Regulation(1997)160 cited
- → Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia(2014)142 cited
- → Widespread expression in adult rat forebrain of mRNA encoding high-affinity neurotensin receptor(1998)104 cited
- → Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension(2022)90 cited
- → Activin receptor antagonists for cancer-related anemia and bone disease(2012)57 cited
- → Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes(2020)55 cited
- → Evidence that Neurotensin Participates in the Central Regulation of the Preovulatory Surge of Luteinizing Hormone in the Rat*(1989)47 cited
- → Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-β Superfamily Signaling(2022)45 cited
- → Vasoactive Intestinal Polypeptide Effects a Central Inhibition of Pulsatile Luteinizing Hormone Secretion in Ovariectomized Rats*(1985)44 cited